PHS
PFM Health Sciences Portfolio holdings
AUM
$1.15B
This Quarter Return
-6.81%
1 Year Return
+21.39%
3 Year Return
+130.75%
5 Year Return
+265.32%
10 Year Return
+1,236.5%
AUM
$2.56B
AUM Growth
+$2.56B
(-1.1%)
Cap. Flow
+$231M
Cap. Flow
% of AUM
9.01%
Top 10 Holdings %
Top 10 Hldgs %
34.93%
Holding
85
New
16
Increased
21
Reduced
12
Closed
9
Top Buys
| 1 |
Merck
MRK
|
$88.6M |
| 2 |
Axsome Therapeutics
AXSM
|
$52.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$50M |
| 4 |
Veeva Systems
VEEV
|
$40.1M |
| 5 |
argenx
ARGX
|
$39.7M |
Top Sells
| 1 |
Outset Medical
OM
|
$128M |
| 2 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$34.1M |
| 3 |
Syndax Pharmaceuticals
SNDX
|
$28.1M |
| 4 |
Heron Therapeutics
HRTX
|
$20.1M |
| 5 |
HCA Healthcare
HCA
|
$20.1M |
Sector Composition
| 1 | Healthcare | 95.76% |
| 2 | Financials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$427B
| $109M | 4.16% | 615,064 +30,181 | +5% | +$5.36M |
|
2
Cytokinetics
CYTK
$4.23B
| $96.9M | 3.69% | 2,465,016 | – | – |
|
3
Eli Lilly
LLY
$657B
| $96.8M | 3.69% | 298,643 | – | – |
|
4
Centene
CNC
$14.3B
| $94.1M | 3.59% | 1,112,480 | – | – |
|
5
Jazz Pharmaceuticals
JAZZ
$7.75B
| $89.2M | 3.4% | 571,936 +55,530 | +11% | +$8.66M |
|
|
6
Merck
MRK
$210B
| $88.6M | 3.38% | +971,998 | New | +$88.6M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $87.1M | 3.32% | 1,091,840 | – | – |
|
8
Arcus Biosciences
RCUS
$1.13B
| $84.8M | 3.23% | 3,346,458 -84,552 | -2% | -$2.14M |
|
9
Humana
HUM
$36.5B
| $77.7M | 2.97% | 166,066 | – | – |
|
10
Pfizer
PFE
$141B
| $70.4M | 2.69% | 1,343,384 | – | – |
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $69.6M | 2.65% | 839,371 +120,876 | +17% | +$10M |
|
12
Avantor
AVTR
$9.18B
| $64.7M | 2.47% | 2,079,657 | – | – |
|
13
UnitedHealth
UNH
$281B
| $57.3M | 2.19% | 111,554 | – | – |
|
14
iRhythm Technologies
IRTC
$5.46B
| $53.3M | 2.03% | 493,721 | – | – |
|
|
15
Axsome Therapeutics
AXSM
$6.05B
| $52.1M | 1.99% | +1,360,596 | New | +$52.1M |
|
|
SGEN
16
DELISTED
Seagen Inc. Common Stock
SGEN
| $50M | 1.91% | +282,395 | New | +$50M |
|
17
IQVIA
IQV
$32.4B
| $48.1M | 1.84% | 221,696 | – | – |
|
18
Dynavax Technologies
DVAX
$1.19B
| $47.9M | 1.83% | 3,805,370 | – | – |
|
19
Danaher
DHR
$147B
| $44.5M | 1.7% | 175,690 | – | – |
|
20
uniQure
QURE
$896M
| $41.7M | 1.59% | 2,236,370 +1,701,746 | +318% | +$31.7M |
|
21
Molina Healthcare
MOH
$9.8B
| $40.2M | 1.53% | 143,779 | – | – |
|
|
22
Veeva Systems
VEEV
$44B
| $40.1M | 1.53% | +202,387 | New | +$40.1M |
|
23
ICU Medical
ICUI
$3.15B
| $39.8M | 1.52% | 242,185 +21,598 | +10% | +$3.55M |
|
|
24
argenx
ARGX
$43.6B
| $39.7M | 1.51% | +104,732 | New | +$39.7M |
|
25
Waters Corp
WAT
$18B
| $38.9M | 1.49% | 117,634 | – | – |
|